Walleye Capital
COLL icon

Walleye Capital’s Collegium Pharmaceutical COLL Stock Holding History

Walleye Capital’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-39,708
Closed -$1.84M – 4478
2025
Q4 		$1.84M Sell
39,708
-189,479
-83% -$7.93M 0.01% 1944
2025
Q3 		$8.02M Buy
+229,187
New +$7.97M 0.03% 643
2025
Q1 		– Sell
-24,512
Closed -$702K – 4365
2024
Q4 		$702K Buy
+24,512
New +$811K ﹤0.01% 2695

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Walleye Capital's COLL Position: Q1 2026 in Review

Walleye Capital sold out of Collegium Pharmaceutical (COLL) in Q1 2026, closing a stake of 39,708 shares — an estimated $1.84M sold.

Walleye Capital first reported a position in COLL in Q4 2024 and held it in 3 quarters. The position peaked at $8.02M in Q3 2025. 267 funds tracked by Wall St. Rank hold COLL as of Q1 2026.

  • Walleye Capital reported no remaining Collegium Pharmaceutical position as of Q1 2026 after selling out during the quarter.
  • Walleye Capital sold 39,708 Collegium Pharmaceutical shares in Q1 2026, an estimated $1.84M.
  • Walleye Capital first reported a position in Collegium Pharmaceutical in Q4 2024 and held it in 3 quarters.
  • Walleye Capital's Collegium Pharmaceutical position peaked at $8.02M in Q3 2025.
  • 267 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.